Literature DB >> 24059259

The nature of verbal memory impairment in multiple sclerosis: a list-learning and meta-analytic study.

Jose M Lafosse1, Sandra M Mitchell, John R Corboy, Christopher M Filley.   

Abstract

The primary purpose of this study was to test the hypothesis that multiple sclerosis (MS) patients have impaired acquisition rather than a retrieval deficit. Verbal memory impairment in MS was examined in 53 relapsing-remitting MS patients and 31 healthy controls (HC), and in a meta-analysis of studies that examined memory functioning in MS with list-learning tasks. The MS group demonstrated significantly lower acquisition and delayed recall performance than the HC group, and the meta-analysis revealed that the largest effect sizes were obtained for acquisition measures relative to delayed recall and recognition. Our data argue against a retrieval deficit as the sole explanation for verbal memory impairment in MS, and make a consistent case for the position that deficient acquisition contributes to the memory dysfunction of MS patients. Deficient acquisition may result from demyelination in relevant white matter tracts that reduces encoding efficiency as a result of impaired speed of information processing.

Entities:  

Mesh:

Year:  2013        PMID: 24059259     DOI: 10.1017/S1355617713000957

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  8 in total

1.  Preconditioning with partial caloric restriction confers long-term protection against grey and white matter injury after transient focal ischemia.

Authors:  Jia Zhang; Wenting Zhang; Xuguang Gao; Yongfang Zhao; Di Chen; Na Xu; Hongjian Pu; R Anne Stetler; Yanqin Gao
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-04       Impact factor: 6.200

Review 2.  Quantitative Meta-analyses of Cognitive Abilities in Children With Pediatric-onset Multiple Sclerosis.

Authors:  Elena S Lysenko; Mariia D Bogdanova; Marie Arsalidou
Journal:  Neuropsychol Rev       Date:  2022-07-08       Impact factor: 7.444

Review 3.  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.

Authors:  Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen
Journal:  Geriatrics (Basel)       Date:  2022-06-05

4.  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.

Authors:  Dejan Jakimovski; Niels Bergsland; Michael G Dwyer; Jesper Hagemeier; Deepa P Ramasamy; Kinga Szigeti; Thomas Guttuso; David Lichter; David Hojnacki; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov
Journal:  Neurobiol Aging       Date:  2020-02-08       Impact factor: 4.673

5.  Relationship Between Anxiety and Cognition in Multiple Sclerosis: Implications for Treatment.

Authors:  Nicholas A Vissicchio; Caroline Altaras; Amanda Parker; Shonna Schneider; Jeffrey G Portnoy; Roseanne Archetti; Marnina Stimmel; Frederick W Foley
Journal:  Int J MS Care       Date:  2019 Jul-Aug

6.  A network-based cognitive training induces cognitive improvements and neuroplastic changes in patients with relapsing-remitting multiple sclerosis: an exploratory case-control study.

Authors:  Riccardo Manca; Micaela Mitolo; Iain D Wilkinson; David Paling; Basil Sharrack; Annalena Venneri
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

7.  The Relationship between Psychosocial Factors and Cognition in Multiple Sclerosis.

Authors:  Fahad D Alosaimi; Alaa AlMulhem; Mario Moscovici; Hanan AlShalan; Mohammad Alqazlan; Abdulgader Aldaif; Sanjeev Sockalingam
Journal:  Behav Neurol       Date:  2017-05-06       Impact factor: 3.342

8.  Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma.

Authors:  Zahra Alirezaei; Alireza Amouheidari; Masoud Hassanpour; Fariba Davanian; Sajjad Iraji; Parvaneh Shokrani; Mohammad-Reza Nazem-Zadeh
Journal:  Biomed Res Int       Date:  2021-03-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.